We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




New Products Increase Cell Cryopreservation Options

By LabMedica International staff writers
Posted on 05 Jul 2011
Biotech researchers and other life scientists will soon have additional options for the collection, organization, protection, freezing, thawing, cooling, and cryopreservation of delicate biological samples.

A leader in the field of cryopreservation, BioCision (Mill Valley, CA, USA) has announced the launch of three new cryopreservation systems. More...
These innovative products include CoolCell FTS30, a large-capacity, high-density cell freezing system; CoolCell SV2 for freezing cells in larger diameter two milliliter vials; and CoolCell five milliliter for large cryovial freezing.

These products incorporate patented alloy-based technology that allows maintenance-free operation as an alternative to conventional freezing methods or programmable freezers. All CoolCell products are designed to deliver a controlled freezing rate of minus 1° C per minute in a -80 °C freezer, with high reproducibility of freezing profiles and consistent cell viability and function after thawing.

The CoolCell FTS30 holds 30 mL screw-cap cryotubes that are suitable for all types of cells including cell lines, stem cells, primary cells, and yeast. The unit may be used "off the shelf" without any maintenance or precooling. Samples are ready for archive storage in four hours packed in a unit sized to fit compactly inside any -80 °C freezer.

"In many areas of biological research, the ability to freeze and thaw samples of cells is absolutely critical to successful experiments. Yet, all too often, this simple procedure is subject to considerable and unnecessary variation, as well as high cost. CoolCell FTS30 solves this problem," said Brian Schryver, vice-president of research and development at BioCision. "Selling for a fraction of the price of commercial cell cryopreservation devices and sized to fit compactly inside any -80 degrees Celsius freezer, this new CoolCell makes a powerful research tool available to all scientists."

Related Links:
BioCision



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
D-Dimer Test
Epithod 616 D-Dimer Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.